Total revenue of $38 million, compared to $485 million in FY 2022 Total cumulative partner-initiated program starts with downstreams of 87, with 12 new starts in the year Net loss… Read More
TORONTO, ON – JDRF and Sanofi Canada are announcing a partnership aimed at amplifying awareness around type 1 diabetes (T1D), a chronic autoimmune condition, and the role screening could play in the… Read More
Scientific Journal Article follows notable IP updates, including publication of key PCT Patent Application, presentation at International Society for Research into Psychedelics Conference VANCOUVER, BC – PharmAla Biotech Holdings Inc. (“PharmAla”… Read More
TORONTO, ON & KIRKLAND, QC ‒ In partnership with Crohn’s and Colitis Canada, we are thrilled to announce our 2024 IBD research joint awards program, now in its fifth year,… Read More
Commercialization of rPEG lipids designed to improve immunogenicity profile for nucleic acid delivery rPEGs to be part of Evonik’s specialized lipid platform Latest step in strategy to grow business in… Read More
